Investors


BioHemp International (OTC:BKIT)
244 5th Avenue, Suite A-154
New York, NY 10001
Phone: 646-453-4912
Email: D_B@BIOHEMPINTERNATIONAL.COM

ACCOUNTING

Bingham and Company
1275 6th Street, Suite 300
Vancouver, BC V6H 1A6
Canada

SECURITIES COUNSEL

The Doney Law Firm
4955 S. Durango Drive, Suite 165
Las Vegas, NV 89113

FINANCIAL REPORTING

Reporting Status: SEC Reporting
Financials: Audited

CIK: 0001556416
Fiscal Year End:8/31

OTC Exchange Symbol: BKIT

SEC Filings & Disclosures
https://www.otcmarkets.com/stock/bkit/disclosure


To request an investor packet on company, or to receive future updates, please join our Investor Mailing List below

X